ECM
PMVP icon

ExodusPoint Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

ExodusPoint Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-38,238
Closed -$235K – 1930
2023
Q3 		$235K Buy
+38,238
New +$263K ﹤0.01% 1481
2023
Q2 		– Sell
-15,698
Closed -$75K – 2170
2023
Q1 		$75K Buy
15,698
+262
+2% +$1.84K ﹤0.01% 1649
2022
Q4 		$134K Sell
15,436
-17,819
-54% -$190K ﹤0.01% 1500
2022
Q3 		$396K Buy
+33,255
New +$480K 0.01% 1442

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

ExodusPoint Capital Management's PMVP Position: Q4 2023 in Review

ExodusPoint Capital Management sold out of PMV Pharmaceuticals (PMVP) in Q4 2023, closing a stake of 38,238 shares — an estimated $235K sold.

ExodusPoint Capital Management first reported a position in PMVP in Q3 2022 and held it in 4 quarters. The position peaked at $396K in Q3 2022. 98 funds tracked by Wall St. Rank hold PMVP as of Q4 2023.

  • ExodusPoint Capital Management reported no remaining PMV Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • ExodusPoint Capital Management sold 38,238 PMV Pharmaceuticals shares in Q4 2023, an estimated $235K.
  • ExodusPoint Capital Management first reported a position in PMV Pharmaceuticals in Q3 2022 and held it in 4 quarters.
  • ExodusPoint Capital Management's PMV Pharmaceuticals position peaked at $396K in Q3 2022.
  • 98 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.